# In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia

> **NCT00785018** · NA · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Endotoxemia
- Inflammation
- Multi Organ Dysfunction Syndrome

## Interventions

- **DRUG:** C1-esterase inhibitor
- **DRUG:** Endotoxin administration

## Key facts

- **NCT ID:** NCT00785018
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2008-12
- **Final completion:** 2009-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2011-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00785018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00785018, "In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00785018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*